non responders to semaglutide GLP-1 nonresponders: Up 1 in 5 people don't lose weight Tirzepatide vs. Semaglutide for Weight
Description
We invite you to take the next steps towards a healthier, more confident version of yourself
Risk of Overdose and Contamination Self-administering smaller doses carries the risk of overdose if a patient miscalculates or adjusts the dose incorrectly
Immediate-release forms of the drug act quickly but have a shorter duration, necessitating multiple doses throughout the day, while extended-release forms provide a more consistent level of medication throughout the day
Signs of gastroesophageal reflux disease (GERD)
In any case, go slow as for some the tweak may worsen bloating or gas during dose adjustment
Book a complimentary consultation and let our licensed professionals help you choose the safest and most effective option
